NAD+ IV Therapy: Cellular Energy Coenzyme — Systemic Levels Achieved in 1 IV Session Not Achievable Orally
NAD+ (nicotinamide adenine dinucleotide) is an essential coenzyme found in every living cell that serves as the central electron carrier in cellular energy production, a required substrate for DNA repair enzymes (sirtuins and PARPs), and a key regulator of mitochondrial function — and its intracellular levels decline by approximately 50% between ages 40 and 60.
NAD+ is listed in the peptide section because it is administered via IV infusion as part of the peptide and optimization protocol line at Rebuild Regen Medical Clinic, though it is technically a coenzyme rather than a peptide. Its clinical applications overlap substantially with the aging, recovery, and cellular optimization goals of the peptide protocols, and it is frequently combined with other optimization compounds.
The IV administration distinction matters: oral NAD+ precursors (NMN, NR) provide substrate for endogenous NAD+ synthesis but produce modest, variable NAD+ elevation. IV NAD+ bypasses GI absorption and first-pass metabolism entirely, achieving plasma and cellular NAD+ levels in a single session that oral supplementation cannot match.
What NAD+ Is — Coenzyme, Electron Carrier, and Aging Marker
Nicotinamide adenine dinucleotide exists in two forms: NAD+ (oxidized, the biologically active form) and NADH (reduced, produced after NAD+ accepts electrons). The cycle between NAD+ and NADH is the fundamental engine of cellular respiration — the process by which cells convert nutrients into ATP (energy).
Beyond energy production, NAD+ is the required substrate for:
Sirtuins (SIRT1-SIRT7): A family of deacetylase enzymes that regulate gene expression, DNA repair, inflammation, and metabolic function. Sirtuins consume NAD+ to function. As NAD+ declines with age, sirtuin activity declines, reducing the cellular maintenance functions sirtuins provide.
PARP enzymes: Poly-ADP-ribose polymerases (PARPs) use NAD+ to detect and repair DNA damage. Reduced NAD+ limits the rate of DNA repair, allowing accumulation of DNA damage — a hallmark of aging.
CD38: An enzyme involved in immune function that also consumes NAD+. CD38 activity increases with age and inflammation, contributing to the accelerated NAD+ decline in older adults.
The practical result of declining NAD+ is reduced cellular energy capacity, slower DNA repair, reduced mitochondrial function, and impaired sirtuin-mediated cellular maintenance — the composite cellular picture of biological aging.
Clinical Applications
Anti-aging and cellular optimization: IV NAD+ is foundational in longevity protocols at Rebuild Regen, providing the coenzyme substrate that sirtuins, PARPs, and mitochondrial complexes need to function optimally. Patients pursuing biological age optimization use NAD+ alongside Epithalon, Thymalin, and the CJC-1295/Ipamorelin stack.
Cognitive function and brain energy: The brain has exceptionally high energy demands. Age-related NAD+ decline impairs neuronal energy production and cognitive function. IV NAD+ produces noticeable improvements in mental clarity, processing speed, and cognitive endurance that many patients describe as among the most immediate effects of any protocol.
Post-illness recovery: COVID-related fatigue, chemotherapy-related fatigue, and post-illness cellular depletion states benefit from NAD+ restoration. The mitochondrial recovery effect is particularly relevant in conditions where cellular energy depletion is a primary complaint.
Addiction recovery support: NAD+ has been used in addiction medicine as part of detoxification protocols, particularly for opioid and alcohol withdrawal. The mechanism involves restoring neurochemical balance and cellular energy that is significantly depleted in addiction states. Elizabeth coordinates with appropriate providers when addiction is part of the clinical context.
Neuropathy support: In the Rebuild Neuropathy Protocol™, IV NAD+ is included as part of the IV nutritional infusion component, supporting mitochondrial function in damaged nerve tissue alongside B12, ALA, and thiamine.
The IV NAD+ Session
IV NAD+ is administered in a clinical setting with slow infusion over 2 to 4 hours. The slow rate is required because faster infusion produces chest tightness, nausea, and flushing — uncomfortable but not dangerous effects that resolve when the infusion rate is reduced. Elizabeth and clinical staff monitor all NAD+ infusions.
Standard sessions deliver 250 to 1000 mg depending on the protocol and the patient's tolerance and goals. Most patients receive a series of 2 to 5 sessions initially, then maintenance sessions every 1 to 3 months.
Frequently Asked Questions
Is oral NMN or NR as effective as IV NAD+?
Oral NAD+ precursors (NMN and NR) are substrate for endogenous NAD+ synthesis and produce modest, clinically meaningful NAD+ elevation with consistent use. IV NAD+ achieves plasma levels immediately and more dramatically than oral precursors, particularly relevant for patients seeking significant short-term NAD+ restoration or who have significant cellular depletion. Many patients use both: IV sessions for acute restoration and oral precursors for maintenance between sessions.
Why does IV NAD+ cause discomfort?
The flushing, chest tightness, and nausea during NAD+ infusion are thought to be mediated by niacin receptor activation (GPR109A) at high plasma concentrations. These effects are rate-dependent — slower infusion reduces or eliminates them. Elizabeth manages infusion rate to the patient's tolerance.
How quickly do patients notice effects?
Cognitive clarity and energy are often among the most immediate responses — many patients notice sharpened mental function during or immediately after the first session. Mitochondrial and cellular recovery effects accumulate over a series of sessions.
When IV NAD+ Is Not Appropriate
IV NAD+ is not appropriate for patients with significant cardiovascular instability who cannot tolerate the autonomic effects of niacin receptor activation, active malignancy without oncology clearance, or pregnancy. The 2 to 4 hour session duration is a practical consideration for patients with significant scheduling constraints. Elizabeth evaluates all relevant clinical factors before the first session.
Rebuild Regen Medical Clinic 3320 N Federal Hwy #101, Lighthouse Point, FL 33064 (954) 953-4208 | rebuildregenmedical.com
Ready to Start Your Recovery?
Schedule a consultation with Rebuild Regen Medical Clinic in Lighthouse Point, FL.